Immunosuppressant combination

2 marketed 3 in Phase 3

This page covers all Immunosuppressant combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Calcineurin (ciclosporin); IMPDH type II (mycophenolate mofetil), Calcineurin (tacrolimus); IMPDH type II (MMF), Calcineurin (tacrolimus); Inosine monophosphate dehydrogenase (mycophenolate mofetil).

Targets

Calcineurin (ciclosporin); IMPDH type II (mycophenolate mofetil) · Calcineurin (tacrolimus); IMPDH type II (MMF) · Calcineurin (tacrolimus); Inosine monophosphate dehydrogenase (mycophenolate mofetil) · IMPDH (mycophenolate); glucocorticoid receptor (dexamethasone)

Marketed (2)

Phase 3 pipeline (3)